HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe.

HIV-1 envelope sequence patterns have implications for virus cell tropism and for the development of an effective vaccine. To identify the sequence characteristics of recently transmitted HIV-1 isolates in southern Africa, we sequenced the V3-V5 envelope regions of 24 male seroconverters in Harare, Zimbabwe. Each of the sequences clustered with previously reported subtype C isolates and there was a mean 17% intersequence pairwise genetic distance between the Zimbabwean isolates. Three isolates were syncytium inducing (SI). One of the SI isolates had an unusual GIGK crown and a deletion at codon 23; one had the codon 23 deletion alone; and one had a high net positive charge in the V3 loop. The extensive genetic diversity within the envelope of subtype C HIV-1 isolates must be considered in vaccine development. Further analysis of subtype C SI isolates and site-directed mutagenesis experiments are required to determine the molecular basis of SI activity in global HIV-1 isolates.

[1]  J. Albert,et al.  Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. , 1999, AIDS research and human retroviruses.

[2]  S. Engelbrecht,et al.  HIV type 1 V3 domain serotyping and genotyping in Gauteng, Mpumalanga, KwaZulu-Natal, and Western Cape Provinces of South Africa. , 1999, AIDS research and human retroviruses.

[3]  C. Williamson,et al.  A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populations. , 1999, AIDS research and human retroviruses.

[4]  M. Peeters,et al.  Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[5]  D. Katzenstein,et al.  Primary subtype C HIV-1 infection in Harare, Zimbabwe. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[6]  J. Albert,et al.  Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. , 1998, Virology.

[7]  R. Lal,et al.  CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. , 1998, Virology.

[8]  D. Katzenstein,et al.  Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes , 1997, Journal of virology.

[9]  D. Katzenstein,et al.  Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe , 1997, Journal of virology.

[10]  E. Halapi,et al.  Role of immunity in maternal—infant HIV‐1 transmission , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[11]  L. Soto-Ramírez,et al.  HIV-1 pol sequences from India fit distinct subtype pattern. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[12]  S. Mallal,et al.  Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohort , 1996, AIDS.

[13]  R. Bollinger,et al.  Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India. , 1996 .

[14]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[15]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[16]  A. Lalvani,et al.  HIV epidemic in India: opportunity to learn from the past , 1996, The Lancet.

[17]  D. Ho,et al.  Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission , 1996, Journal of virology.

[18]  D J Hu,et al.  The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. , 1996, JAMA.

[19]  B. Korber,et al.  Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes , 1996, Journal of virology.

[20]  A. Sönnerborg,et al.  Multiple enhancer motifs in HIV type 1 strains from Ethiopia. , 1995, AIDS research and human retroviruses.

[21]  B. Korber,et al.  Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. WHO Network for HIV Isolation and Characterization. , 1994, AIDS research and human retroviruses.

[22]  E. G. Shpaer,et al.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. , 1993, Science.

[23]  D. Ho,et al.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.

[24]  J. Lundgren,et al.  Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection , 1993, AIDS.

[25]  H. Schuitemaker,et al.  Relation of phenotype evolution of HIV-1 to envelope V2 configuration. , 1993, Science.

[26]  A. Cann,et al.  A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism , 1993, Journal of virology.

[27]  D. Cooper,et al.  Augmentation of HIV‐specific lymphoproliferation in HIV‐infected individuals by TraT: a novel T‐cell immunopotentiating agent , 1993, AIDS.

[28]  I. Keet,et al.  Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS , 1993, Annals of Internal Medicine.

[29]  Rainer Fuchs,et al.  CLUSTAL V: improved software for multiple sequence alignment , 1992, Comput. Appl. Biosci..

[30]  M. Roos,et al.  Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. , 1992, The Journal of infectious diseases.

[31]  E. Freed,et al.  Identification of conserved residues in the human immunodeficiency virus type 1 principal neutralizing determinant that are involved in fusion. , 1991, AIDS research and human retroviruses.

[32]  B. Cullen,et al.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.

[33]  Huisman,et al.  Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex , 1988, Journal of virology.

[34]  C. Cheng‐Mayer,et al.  Biologic features of HIV-1 that correlate with virulence in the host. , 1988, Science.

[35]  D. Katzenstein,et al.  Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. , 1999, AIDS research and human retroviruses.

[36]  C. Rinaldo,et al.  Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties. , 1991, Virology.